Pharma Deals Review, Vol 2007, No 85 (2007)

Font Size:  Small  Medium  Large

Synosia Licenses Parkinson’s Compound from Syngenta

Business Review Editor

Abstract


Syngenta and Synosia Therapeutics entered into license agreement for Syngenta’s SYN-118 for treating hereditary tyrosinemia type I.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.